Skip to main content
CGC logo

Canopy Growth Corporation (CGC) Stock Price & Analysis

Canopy Growth Corporation (CGC) — MoonshotScore 16/100 (Weak band), calculated Nov 18, 2026. Price $0.4743 (-5.42%), as of the Nov 19, 2026 trading session; market cap $213M.

Educational signal · not a buy or sell recommendation · How to read this

$0.4743 −$0.0272 (-5.42%) Market Cap $213M

Canopy Growth Corporation · CGC · NASDAQ

Canopy Growth Corporation is a leading cannabis company focused on producing and distributing cannabis and hemp-based products. The company operates in Canada, the United States, and Germany, targeting both recreational and medical markets.

Price as of Nov 19, 2026

Key Statistics

16 of 100

MoonshotScore v2 · Canopy Growth (CGC)

Weak
Business Quality Thin (25)
Financial Safety Fragile (7)
Valuation Fair (66)
Growth Durability Fading (31)
Momentum Slipping (28)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Weak quality, a fragile balance sheet and weak growth, and the price trend has turned against it. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and losses on top of negative retained earnings. Business Quality: Thin; Financial Safety: Fragile; Valuation: Fair; Growth Durability: Fading; Momentum: Slipping.

  • EPS beat 3 of the last 8 reports
  • Altman Z -14.47 · Piotroski F 3
  • ROE -39.4% · ROA -26.0% · current ratio 2.82 · earnings yield -80.2% · free-cash-flow yield -22.4%

Holding back: weak fundamentals, balance-sheet strain, soft growth, weak price trend

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for CGC (52 recorded, newest six shown)
RecordedScoreBand
16Weak
16Weak
16Weak
16Weak
16Weak
16Weak

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$0.4743
Change on the day-5.42%
52-week range$0.4743 – $2.38
Market capitalisation$213M—
Shares traded on the day3.49M

Price & events

Other perspectives

Council score for Canopy Growth (CGC): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Weak
Financial Safety Negative
Valuation Moderate
Growth Durability Weak
Momentum Weak

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Neutral read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Unfavorable read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Neutral read

Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Negative
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Neutral
Debt/Equity Neutral
ROE Negative
Gross Margin Weak

Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 16, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Canopy Growth (CGC), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Canopy Growth Corporation (CGC) is listed on NASDAQ. It employs 1,128 people and is led by Luc Mongeau. The market values it at $213M.

2 · Latest results

What do the latest results show for Canopy Growth (CGC)?

Short answer · as of

Against analyst estimates the company has EPS beat 3 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Sep 2026C$81M-C$41M-C$0.10 (diluted)
Q1 FY2027C$81M-C$15M-C$0.03 (diluted)
Q4 FY2026C$71M-C$157M-C$0.41 (diluted)
Q3 FY2026C$102M-C$86M-C$0.25 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Canopy Growth (CGC)?

Short answer · as of

What is holding it back is weak fundamentals, balance-sheet strain, soft growth, weak price trend. The distress and quality screens read Altman Z -14.47 · Piotroski F 3. Trailing ratios: ROE -39.4% · ROA -26.0% · current ratio 2.82 · earnings yield -80.2% · free-cash-flow yield -22.4%.

Data-derived red flags

  • Listing risk — at $0.4743 the shares sit below the $1.00 minimum bid NASDAQ requires for continued listing.
  • Financial-distress signal — its Altman Z-Score of -14.47 sits in the distress zone (elevated bankruptcy risk).
  • Negative return on equity (-39.4%) — the business is not currently generating profit on shareholder capital.
5 · Peer comparison

How does Canopy Growth compare with its peers?

Short answer

Canopy Growth's score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Cronos Group Inc. (CRON) Named competitor$3.17 Nov 18, 2026$1.16B95 5-pillar Nov 18, 2026
Kamada Ltd. (KMDA) Same industry, near in market value$8.07 Nov 18, 2026$466M87 5-pillar Nov 18, 2026
Embecta Corp. (EMBC) Same industry, near in market value$6.19 Nov 19, 2026$351M71 5-pillar Nov 18, 2026
Cumberland Pharmaceuticals Inc. (CPIX) Same industry, near in market value$6.57 Nov 18, 2026$98.5M51 5-pillar Nov 18, 2026
Cardiol Therapeutics Inc. (CRDL) Same industry, near in market value$0.88 Nov 19, 2026$113M49 5-pillar Nov 18, 2026
SIGA Technologies, Inc. (SIGA) Same industry, near in market value$2.65 Nov 19, 2026$190M38 5-pillar Nov 18, 2026
Alpha Teknova, Inc. (TKNO) Same industry, near in market value$7.81 Nov 19, 2026$491M34 5-pillar Nov 18, 2026
SNDL Inc. (SNDL) Same industry, near in market value$1.24 Nov 19, 2026$302M32 5-pillar Nov 18, 2026
Journey Medical Corporation (DERM) Same industry, near in market value$3.55 Nov 19, 2026$100M31 5-pillar Nov 18, 2026
Organogenesis Holdings Inc. (ORGO) Same industry, near in market value$0.85 Nov 18, 2026$111M28 5-pillar Nov 18, 2026
Emergent BioSolutions Inc. (EBS) Same industry, near in market value$5.15 Nov 19, 2026$265M24 5-pillar Nov 18, 2026
Lifecore Biomedical, Inc. (LFCR) Same industry, near in market value$6.37 Nov 19, 2026$241M21 5-pillar Nov 18, 2026
Canopy Growth (CGC) — this page$0.4743$213M16

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Sep 28, 2026

Transactions
24
Identified insiders
7
Purchases
0
Sales
14
Other transactions
10

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held CGC in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported CGC in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Canopy Growth (CGC)?

Read these with our analysis →

Canopy Growth Stock: Key Questions Answered

These answers are editorial: 1 of these 9 answers is drawn from the CGC research dossier (written May 10, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for CGC?

CGC carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Canopy Growth Corporation is a leading cannabis company focused on producing and distributing cannabis and hemp-based products.

Is CGC a good stock to buy?

Stock Expert AI does not rate CGC buy, sell or hold. Canopy Growth Corporation carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the CGC stock price today?

The last price recorded for Canopy Growth Corporation (CGC), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is Canopy Growth Corporation's strategy for competing with illicit cannabis markets?

Canopy Growth Corporation combats illicit cannabis markets through several strategies. The company focuses on offering high-quality, tested, and regulated cannabis products that appeal to consumers seeking safe and reliable options.

What are the key factors to evaluate for CGC?

Canopy Growth Corporation (CGC) holds a MoonshotScore in the low range. These partnerships and acquisitions can drive revenue growth and improve profitability. Not financial advice.

How frequently does CGC data refresh on this page?

CGC's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven CGC's recent stock price performance?

Canopy Growth Corporation (CGC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider CGC overvalued or undervalued right now?

Canopy Growth Corporation (CGC) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of CGC?

Fractional-share availability for Canopy Growth Corporation (CGC) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 13 figures on this page — 5 from Financial Modeling Prep (FMP), 7 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.